Estimating the Clinical and Economic Benefit Associated with Incremental Improvements in Sustained Virologic Response in Chronic Hepatitis C

• Phil McEwan ,

  * E-mail: phil.mcewan@heor.co.uk

  Affiliations HEOR Ltd, Singleton Court Business Park, Monmouth, Wales, United Kingdom, Swansea Centre for Health Economics, School of Human & Health Sciences, Swansea University, Wales, United Kingdom

  ⨯
• Thomas Ward,

  Affiliations HEOR Ltd, Singleton Court Business Park, Monmouth, Wales, United Kingdom, Swansea Centre for Health Economics, School of Human & Health Sciences, Swansea University, Wales, United Kingdom

  ⨯
• Hayley Bennett,

  Affiliation HEOR Ltd, Singleton Court Business Park, Monmouth, Wales, United Kingdom

  ⨯
• Anupama Kalsekar,

  Affiliation Global Health Economics and Outcomes Research, Bristol-Myers Squibb, Princeton, New Jersey, United States of America

  ⨯
• Samantha Webster,

  Affiliation HEOR Ltd, Singleton Court Business Park, Monmouth, Wales, United Kingdom

  ⨯
• Michael Brenner,

  Affiliation Bristol-Myers Squibb, Uxbridge, Middlesex, United Kingdom

  ⨯
• Yong Yuan

  Affiliation Global Health Economics and Outcomes Research, Bristol-Myers Squibb, Princeton, New Jersey, United States of America

  ⨯